Long Term Oxygen Therapy in Patients With Interstitial Lung Disease

Sponsor

Assiut University (Other)

Overall Status

Unknown status

CT.gov ID

NCT04089826

Collaborator

(none)

Enrollment

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Study the effect of using long term oxygen therapy in patients with interstitial lung disease and chronic hypoxia

Condition or Disease	Intervention/Treatment	Phase
Long Term Oxygen Therapy Interstitial Lung Disease

Detailed Description

long term oxygen can be used in patients with interstitial lung disease with hypoxia and the aim of this study is to k ow whether this will improve life style , exercise tolerance in those patients

Study Design

Study Type:

Observational

Anticipated Enrollment :

10 participants

Observational Model:

Case-Only

Time Perspective:

Prospective

Official Title:

Role of LTOT in Pateints With ILD

Anticipated Study Start Date :

Sep 1, 2019

Anticipated Primary Completion Date :

Sep 1, 2020

Anticipated Study Completion Date :

Oct 1, 2020

Outcome Measures

Primary Outcome Measures

Dyspnea score improvement [Baseline]
dyspnea by Modified Medical Research Counsel
Quality of life improvement [Baseline]
Quality of life by st.George questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 70 Years

Sexes Eligible for Study:

All

Inclusion Criteria :

patients with ILD and hypoxia with SO2<88 at room air and PO2 < or equal 7.3k.pa or < or equal 8 k.pa in presence of lower limb edema , pulmonary hypertension or polycythemia
age group 18 : 70

Exclusion Criteria :

Causes of chronic respiratory failure other than ILD.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Cobo-Ibáñez T, López-Longo FJ, Joven B, Carreira PE, Muñoz-Fernández S, Maldonado-Romero V, Larena-Grijalba C, Cubas IL, Muriel ET, Mateos CB, de la Peña Lefebvre PG, Gomez-Gomez A, Nogal LB, Pérez A, Almodovar R, Lojo L, Ruiz-Gutiérrez L, López-Robledillo JC, García de Yébenes MJ, Nuño-Nuño L. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease. Clin Rheumatol. 2019 Mar;38(3):803-815. doi: 10.1007/s10067-018-4353-2. Epub 2018 Nov 3.

Responsible Party:

Asmaa Mahmoud Mohammed Eltayeb, Resident at chest department Assiut university, Assiut University

ClinicalTrials.gov Identifier:

NCT04089826

Other Study ID Numbers:

Role of LTOT in Pateints e ILD

First Posted:

Sep 13, 2019

Last Update Posted:

Sep 16, 2019

Last Verified:

Aug 1, 2019

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Lung Diseases

Lung Diseases, Interstitial

Study Results

No Results Posted as of Sep 16, 2019